137 related articles for article (PubMed ID: 36042172)
1. Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis.
Guo Q; Qu Q; Wang L; Liao S; Zhu X; Du A; Zhu Q; Cheang I; Gao R; Li X
Front Biosci (Landmark Ed); 2022 Aug; 27(8):246. PubMed ID: 36042172
[TBL] [Abstract][Full Text] [Related]
2. Identification of Immune Markers in Dilated Cardiomyopathies with Heart Failure by Integrated Weighted Gene Coexpression Network Analysis.
Wang X; Guan H; Liu W; Li H; Ding J; Feng Y; Chen Z
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327947
[TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatic analysis reveals immune molecular markers and potential drugs for diabetic cardiomyopathy.
Guo Q; Zhu Q; Zhang T; Qu Q; Cheang I; Liao S; Chen M; Zhu X; Shi M; Li X
Front Endocrinol (Lausanne); 2022; 13():933635. PubMed ID: 36046789
[TBL] [Abstract][Full Text] [Related]
4. Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq.
Fang C; Lv Z; Yu Z; Wang K; Xu C; Li Y; Wang Y
BMC Cardiovasc Disord; 2022 Jul; 22(1):320. PubMed ID: 35850644
[TBL] [Abstract][Full Text] [Related]
5. Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy.
Zhang H; Huo J; Jiang W; Shan Q
Mol Med Rep; 2020 Aug; 22(2):915-925. PubMed ID: 32626989
[TBL] [Abstract][Full Text] [Related]
6. Identification of vital modules and genes associated with heart failure based on weighted gene coexpression network analysis.
Bian W; Wang Z; Li X; Jiang XX; Zhang H; Liu Z; Zhang DM
ESC Heart Fail; 2022 Apr; 9(2):1370-1379. PubMed ID: 35128826
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential dilated cardiomyopathy-related targets by meta-analysis and co-expression analysis of human RNA-sequencing datasets.
Yuan Z; Murakoshi N; Xu D; Tajiri K; Okabe Y; Aonuma K; Murakata Y; Li S; Song Z; Shimoda Y; Mori H; Aonuma K; Ieda M
Life Sci; 2022 Oct; 306():120807. PubMed ID: 35841977
[TBL] [Abstract][Full Text] [Related]
8. Machine learning and bioinformatics to identify 8 autophagy-related biomarkers and construct gene regulatory networks in dilated cardiomyopathy.
Zhang F; Xia M; Jiang J; Wang S; Zhao Q; Yu C; Yu J; Xian D; Li X; Zhang L; Liu Y; Peng M
Sci Rep; 2022 Sep; 12(1):15030. PubMed ID: 36056063
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of AC061961.2, LING01-AS1, and RP11-13E1.5 is associated with dilated cardiomyopathy progression.
Qiu Z; Ye B; Yin L; Chen W; Xu Y; Chen X
J Cell Physiol; 2019 Apr; 234(4):4460-4471. PubMed ID: 30203513
[TBL] [Abstract][Full Text] [Related]
10. Co-expression analysis provides important module and pathways of human dilated cardiomyopathy.
Xiao J; Li F; Yang Q; Zeng XF; Ke ZP
J Cell Physiol; 2020 Jan; 235(1):494-503. PubMed ID: 31236962
[TBL] [Abstract][Full Text] [Related]
11. Identification of important modules and biomarkers in diabetic cardiomyopathy based on WGCNA and LASSO analysis.
Cui M; Wu H; An Y; Liu Y; Wei L; Qi X
Front Endocrinol (Lausanne); 2024; 15():1185062. PubMed ID: 38469146
[TBL] [Abstract][Full Text] [Related]
12. Identification of cuproptosis-related genes and immune infiltration in dilated cardiomyopathy.
Lin Y; Chen K; Guo J; Chen P; Qian ZR; Zhang T
Int J Cardiol; 2024 Mar; 399():131702. PubMed ID: 38168558
[TBL] [Abstract][Full Text] [Related]
13. Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy.
Yang Y; Liu P; Teng R; Liu F; Zhang C; Lu X; Ding Y
Ann Transl Med; 2022 Mar; 10(6):348. PubMed ID: 35433958
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of WGCNA and machine learning identified diagnostic biomarkers in dilated cardiomyopathy with heart failure.
Zhu Y; Yang X; Zu Y
Front Cell Dev Biol; 2022; 10():1089915. PubMed ID: 36544902
[TBL] [Abstract][Full Text] [Related]
15. Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses.
Zhou H; Tan L; Lu T; Xu K; Li C; Liu Z; Peng H; Shi R; Zhang G
Med Sci Monit; 2020 Jun; 26():e924576. PubMed ID: 32581210
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression.
He B; Quan LP; Cai CY; Yu DY; Yan W; Wei QJ; Zhang Z; Huang XN; Liu L
Front Cardiovasc Med; 2022; 9():973279. PubMed ID: 36148059
[TBL] [Abstract][Full Text] [Related]
17. Screening for immune-related biomarkers associated with myasthenia gravis and dilated cardiomyopathy based on bioinformatics analysis and machine learning.
Zhou G; Wang S; Lin L; Lu K; Lin Z; Zhang Z; Zhang Y; Cheng D; Szeto K; Peng R; Luo C
Heliyon; 2024 Apr; 10(7):e28446. PubMed ID: 38571624
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
Wang Z; Xia Q; Su W; Cao M; Sun Y; Zhang M; Chen W; Jiang T
Front Cardiovasc Med; 2022; 9():824756. PubMed ID: 35282347
[TBL] [Abstract][Full Text] [Related]
19. Coexpression network analysis coupled with connectivity map database mining reveals novel genetic biomarkers and potential therapeutic drugs for polymyositis.
Wang K; Zhu R; Li J; Zhang Z; Wen X; Chen H; Sun L
Clin Rheumatol; 2022 Jun; 41(6):1719-1730. PubMed ID: 35091780
[TBL] [Abstract][Full Text] [Related]
20. Weighted correlation network bioinformatics uncovers a key molecular biosignature driving the left-sided heart failure.
Zhou J; Zhang W; Wei C; Zhang Z; Yi D; Peng X; Peng J; Yin R; Zheng Z; Qi H; Wei Y; Wen T
BMC Med Genomics; 2020 Jul; 13(1):93. PubMed ID: 32620106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
